Twenty-four Year Single-Center Experience of Hepatitis B Virus Infection in Heart Transplantation

被引:22
|
作者
Chen, Y. C. [2 ]
Chuang, M. K. [1 ]
Chou, N. K. [1 ]
Chi, N. H. [1 ]
Wu, I. H. [1 ]
Chen, Y. S. [1 ]
Yu, H. Y. [1 ]
Huang, S. C. [1 ]
Wang, C. H. [1 ,2 ]
Tsao, C. I. [1 ]
Ko, W. J. [1 ]
Wang, S. S. [1 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Hsinchu Branch, Dept Surg, Hsinchu, Taiwan
关键词
DONORS;
D O I
10.1016/j.transproceed.2012.03.040
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. Hepatitis B virus (HBV) infection is hyperendemic in Taiwan. We have reported the outcome of (1) recipients with hepatitis B surface antigen (HBsAg)-positive; HBsAg-negative recipients who receive donor hearts from HBsAg-positive donors; and treatment with lamivudine of hepatitis B flare-ups after heart transplantation, using case numbers that range from 100 to 200. Methods. From July 1987 to May 2011, all 412 orthotopic heart transplant recipients and donors underwent routine preoperative screening for hepatitis B virus markers and liver function parameters. Lamivudine was prescribed prophylactically for recipients with elevated serum enzyme levels or an HBV DNA virus load before transplantation, or when there was evidence of hepatitis B flare-up after transplantation. Postoperative HBV markers and liver function parameters were collected over a mean follow-up time of 7.8 years. Results. Thirty-four recipients were HBsAg-positive before heart transplantation, and 23 experiencing REV reactivation upon follow-up requiring lamivudine treatment. Clinical responses were achieved in all of them: 15 were complete and two, slow partial responses. Twenty-six recipients with an HBV naive status at the time of heart transplantation, and three patients received donor hearts from an HBsAg-positive donor under perioperative hepatitis B immunoglobulin prophylaxis. HBV infection was successfully prevented in two patients, but the other one contracted HBV hepatitis, which was successfully treated with lamivudine. Conclusions. HBV reactivation after the heart transplantation was common but usually well controlled with lamivudine treatment. Although posttransplantation liver function deteriorated for a period, there was no HBV infection-related morbidity or mortality. Perioperative hepatitis B immunoglobulin prophylaxis can successfully prevent HBV naive recipients from infection in some cases, but HBsAg-positive donors should only be considered in high risk situations.
引用
收藏
页码:910 / 912
页数:3
相关论文
共 50 条
  • [1] Prophylaxis of hepatitis B virus infection before liver transplantation, 1990-2001: A single-center experience
    Marzano, A
    Gaia, S
    Ciardo, V
    Premoli, A
    Ghisetti, V
    Salizzoni, M
    Rizzetto, M
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (03) : 1020 - 1021
  • [2] Lamivudine for hepatitis B in liver transplantation - A single-center experience
    Malkan, G
    Cattral, MS
    Humar, A
    Al Asghar, H
    Greig, PD
    Hemming, AW
    Levy, GA
    Lilly, LB
    TRANSPLANTATION, 2000, 69 (07) : 1403 - 1407
  • [3] Heart transplantation: A single-center experience
    Pasic, M
    Loebe, M
    Hummel, M
    Grauhan, O
    Hofmeister, J
    Weng, YG
    Hetzer, R
    ANNALS OF THORACIC SURGERY, 1996, 62 (06): : 1685 - 1690
  • [4] A 5-year Single-Center Experience of Hepatitis E Virus Infection During Pregnancy
    Karna, Rahul
    Hazam, Rajib K.
    Borkakoti, Jayanta
    Kumar, Ashok
    Kar, Premashis
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (02) : 135 - 138
  • [5] New era of liver transplantation for hepatitis B - A 17-year single-center experience
    Anselmo, DM
    Ghobrial, RM
    Jung, LC
    Weaver, M
    Cao, C
    Saab, S
    Kunder, G
    Chen, PW
    Farmer, DG
    Yersiz, H
    Baquerizo, A
    Geevarghese, S
    Han, SH
    Goldstein, L
    Holt, CD
    Gornbein, JA
    Busuttil, RW
    ANNALS OF SURGERY, 2002, 235 (05) : 611 - 619
  • [6] Invasive fungal infection after heart transplantation: A 7-year, single-center experience
    Echenique, Ignacio A.
    Angarone, Michael P.
    Gordon, Robert A.
    Rich, Jonathan
    Anderson, Allen S.
    McGee, Edwin C.
    Abicht, Travis O.
    Kang, Joseph
    Stosor, Valentina
    TRANSPLANT INFECTIOUS DISEASE, 2017, 19 (01)
  • [7] Twenty-four year experience with cardiac retransplantation
    Copeland, J. G.
    Herbst, A.
    Bose, R.
    Sethi, G.
    Arabia, F.
    Tsau, P.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2006, 25 (02): : S134 - S134
  • [8] Pediatric heart transplantation: 23-year single-center experience
    Huebler, Michael
    Schubert, Stephan
    Lehmkuhl, Hans Brendan
    Weng, Yuguo
    Miera, Oliver
    Alexi-Meskishvili, Vladimir
    Berger, Felix
    Hetzer, Roland
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2011, 39 (05) : E83 - E89
  • [9] REACTIVATION OF HEPATITIS B VIRUS IN KIDNEY TRANSPLANT RECIPIENTS WITH RESOLVED INFECTION: A SINGLE-CENTER EXPERIENCE
    Pimenta, Goncalo
    Weigert, Andre
    Conde, Sara Querido
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I967 - I968
  • [10] Renal transplantation and hepatitis C virus infection: A single center experience over four years.
    Mendez, RG
    ElShahawy, M
    Aswad, S
    Sabawi, M
    Mendez, R
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3229 - A3229